Furthermore, our preliminary data demonstrated a positive correlation between ALDH2 and IL-17A expression in certain cancers, such as head and neck carcinoma, colon adenocarcinoma, and esophageal cancer. This evidence concerns the gene IL17A and esophageal cancer.